Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatment of Patients With Late-Stage Colorectal Cancer: ASCO Resource-Stratified Guideline
E. Gabriela Chiorean, Govind Nandakumar, Temidayo Fadelu, et al.
JCO Global Oncology (2020), Iss. 6, pp. 414-438
Open Access | Times Cited: 217

Showing 1-25 of 217 citing articles:

Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer
Jeanne Tie, Joshua D. Cohen, Kamel Lahouel, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 24, pp. 2261-2272
Open Access | Times Cited: 643
Treatment of Metastatic Colorectal Cancer: ASCO Guideline
Van K. Morris, Erin B. Kennedy, Nancy N. Baxter, et al.
Journal of Clinical Oncology (2022) Vol. 41, Iss. 3, pp. 678-700
Open Access | Times Cited: 338
Young-onset colorectal cancer
Manon C.W. Spaander, Ann G. Zauber, Sapna Syngal, et al.
Nature Reviews Disease Primers (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 145
Panitumumab vs Bevacizumab Added to Standard First-line Chemotherapy and Overall Survival Among Patients With RAS Wild-type, Left-Sided Metastatic Colorectal Cancer
Jun Watanabe, Kei Muro, Kohei Shitara, et al.
JAMA (2023) Vol. 329, Iss. 15, pp. 1271-1271
Open Access | Times Cited: 136
The Colorectal Cancer Tumor Microenvironment and Its Impact on Liver and Lung Metastasis
Raghav Chandra, John D. Karalis, C. Liu, et al.
Cancers (2021) Vol. 13, Iss. 24, pp. 6206-6206
Open Access | Times Cited: 108
Baseline ctDNA gene alterations as a biomarker of survival after panitumumab and chemotherapy in metastatic colorectal cancer
Kohei Shitara, Kei Muro, Jun Watanabe, et al.
Nature Medicine (2024) Vol. 30, Iss. 3, pp. 730-739
Open Access | Times Cited: 39
Colorectal cancer: Recent advances in management and treatment
Hiba Fadlallah, Jad El Masri, Hiam Fakhereddine, et al.
World Journal of Clinical Oncology (2024) Vol. 15, Iss. 9, pp. 1136-1156
Open Access | Times Cited: 22
Early stage colon cancer: Current treatment standards, evolving paradigms, and future directions
Sakti Chakrabarti, Carrie Y. Peterson, Deepika Sriram, et al.
World Journal of Gastrointestinal Oncology (2020) Vol. 12, Iss. 8, pp. 808-832
Open Access | Times Cited: 104
Fusobacterium nucleatum Acts as a Pro-carcinogenic Bacterium in Colorectal Cancer: From Association to Causality
Shuang Wang, Yang Liu, Jun Li, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 87
Early Detection for Colorectal Cancer: ASCO Resource-Stratified Guideline
Gilberto Lopes, Mariana C. Stern, Sarah Temin, et al.
Journal of Global Oncology (2019), Iss. 5, pp. 1-22
Open Access | Times Cited: 83
The Role of p53 Dysfunction in Colorectal Cancer and Its Implication for Therapy
Maurice Stephan Michel, Leonard Kaps, Annett Maderer, et al.
Cancers (2021) Vol. 13, Iss. 10, pp. 2296-2296
Open Access | Times Cited: 81
TELO2 induced progression of colorectal cancer by binding with RICTOR through mTORC2
Zheng Guo, Xiufang Zhang, Huabin Zhu, et al.
Oncology Reports (2020) Vol. 45, Iss. 2, pp. 523-534
Open Access | Times Cited: 76
The Role of Cancer Stem Cells in Colorectal Cancer: From the Basics to Novel Clinical Trials
Céline Hervieu, Niki Christou, Serge Battu, et al.
Cancers (2021) Vol. 13, Iss. 5, pp. 1092-1092
Open Access | Times Cited: 73
ctDNA and Adjuvant Therapy for Colorectal Cancer: Time to Re-Invent Our Treatment Paradigm
Mahendra Naidoo, Peter Gibbs, Jeanne Tie
Cancers (2021) Vol. 13, Iss. 2, pp. 346-346
Open Access | Times Cited: 59
Tumour-agnostic circulating tumour DNA analysis for improved recurrence surveillance after resection of colorectal liver metastases: A prospective cohort study
Nadia Øgaard, Thomas Reinert, Tenna Vesterman Henriksen, et al.
European Journal of Cancer (2022) Vol. 163, pp. 163-176
Open Access | Times Cited: 49
Colorectal cancer: a comprehensive review of carcinogenesis, diagnosis, and novel strategies for classified treatments
Roya Abedizadeh, Fatemeh Majidi, Hamid Reza Khorasani, et al.
Cancer and Metastasis Reviews (2023) Vol. 43, Iss. 2, pp. 729-753
Closed Access | Times Cited: 37
Metformin: A Dual-Role Player in Cancer Treatment and Prevention
Mariam Ahmed Galal, Mohammed Al-Rimawi, Abdurrahman Hajeer, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4083-4083
Open Access | Times Cited: 17
Circulating tumor DNA for prognosis assessment and postoperative management after curative‐intent resection of colorectal liver metastases
Thomas Reinert, Lena Marie Skindhøj Petersen, Tenna Vesterman Henriksen, et al.
International Journal of Cancer (2022) Vol. 150, Iss. 9, pp. 1537-1548
Open Access | Times Cited: 37
Butyrate facilitates immune clearance of colorectal cancer cells by suppressing STAT1-mediated PD-L1 expression
Yan Zhang, Yuan Tao, Yuqing Gu, et al.
Clinics (2023) Vol. 78, pp. 100303-100303
Open Access | Times Cited: 21
Assessment of Adult Women With Ovarian Masses and Treatment of Epithelial Ovarian Cancer: ASCO Resource-Stratified Guideline
Verna Vanderpuye, Jean R. Clemenceau, Sarah Temin, et al.
JCO Global Oncology (2021), Iss. 7, pp. 1032-1066
Open Access | Times Cited: 40
AGA Clinical Practice Update on Surveillance After Pathologically Curative Endoscopic Submucosal Dissection of Early Gastrointestinal Neoplasia in the United States: Commentary
Andrew Y. Wang, Joo Ha Hwang, Amit Bhatt, et al.
Gastroenterology (2021) Vol. 161, Iss. 6, pp. 2030-2040.e1
Open Access | Times Cited: 39
Neoadjuvant chemotherapy for colorectal liver metastases: A contemporary review of the literature
Marissa Guo, Ning Jin, Timothy M. Pawlik, et al.
World Journal of Gastrointestinal Oncology (2021) Vol. 13, Iss. 9, pp. 1043-1061
Open Access | Times Cited: 38
Shape-Controllable Tellurium-Driven Heterostructures with Activated Robust Immunomodulatory Potential for Highly Efficient Radiophotothermal Therapy of Colon Cancer
Wei Huang, Lizhen He, Zhongyang Zhang, et al.
ACS Nano (2021) Vol. 15, Iss. 12, pp. 20225-20241
Closed Access | Times Cited: 38
The Role of Wild-Type RAS in Oncogenic RAS Transformation
Erin Sheffels, Robert L. Kortum
Genes (2021) Vol. 12, Iss. 5, pp. 662-662
Open Access | Times Cited: 36
Regional Therapy for Colorectal Cancer Liver Metastases: Which Modality and When?
Michael J. Raphael, Paul J. Karanicolas
Journal of Clinical Oncology (2022) Vol. 40, Iss. 24, pp. 2806-2817
Closed Access | Times Cited: 26
Page 1 - Next Page

Scroll to top